TREATMENT DYNAMICS AND DISEASE BURDEN AMONG PATIENTS WITH RELAPSING REMITTING MULTIPLE SCLEROSIS (RRMS) CURRENTLY TREATED WITH DISEASE MODIFYING TREATMENTS (DMTS) IN THE UNITED STATES (US)
Author(s)
Narayanan S1, Khan H2, Gabriele S2, White J2
1Ipsos Healthcare, Columbia, MD, USA, 2Ipsos Healthcare, London, UK
OBJECTIVES: To assess treatment dynamics and disease burden among RRMS patients currently treated with DMTs in the US. METHODS: A multi-center medical chart-review study of MS patients was conducted in 4Q2012 among neurologists to collect de-identified data. Neurologists were screened for duration of practice (>=3yrs) and patient volume (>=15 MS patients/month) and recruited from a large panel to be geographically representative of the US. Medical charts of next 10 consecutive MS patients were abstracted by each neurologist to collect patient diagnosis, treatment patterns and symptomatology/disability-status. RRMS patients currently treated with 1st-line & 2nd-line DMTs were evaluated. RESULTS:
Conference/Value in Health Info
2014-05, ISPOR 2014, Palais des Congres de Montreal
Value in Health, Vol. 17, No. 3 (May 2014)
Code
PND51
Topic
Health Service Delivery & Process of Care
Topic Subcategory
Prescribing Behavior, Treatment Patterns and Guidelines
Disease
Neurological Disorders